Mfg Part Number
Ab00940-10.0
Vector Labs Ab00940-10.0 Anti-Envelope protein (soluble) [Z3L1], Human IgG1, lambda (200 μg)
Quick Overview
Anti-ZIKV mAbs were obtained from the sera and peripheral blood mononuclear cells of a ZIKV-infected patient.
$517.40
Order will ship within 1-3 business days
| Product Class: | Purified |
|---|---|
| Clone ID: | Z3L1 |
| Synonyms: | ZIKV sE; Zika virus soluble envelope protein; Zika virus envelope protein; ZIKV soluble envelope protein; ZIKV envelope protein; Zika virus sE protein; ZIKV sE protein; Z3-L1 |
| Amount: | 200 μg |
| Application Codes Clone: | NTRL; crystallisation; ELISA; FC; SPR |
| Shipping Temperature: | Wet Ice |
| Origin Pub PMID: | 27974667 |
| Buffer Composition: | PBS with 0.02% Proclin 300. |
| Original Format: | IgG1 |
| Storage Temperature: | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C. |
| Specificity Statement: | Z3L1 binds to the ZIKV soluble envelope (sE) protein, shown using SPR, kinetic competition assays and crystallography (Wang et al, 2016). This mAb is highly specific for ZIKV, and was shown to exhibit no neutralisation activity against DENV-1 to DENV-4 virions, which are highly related to ZIKV. It was shown crystallographically that the Z3L1 Fab region binds to domain I and domain II of sE. ZIKV has recently become a major global health concern, following a 2015 outbreak. Viral infection is associated with neurological complications and microencephaly. |
| Application Notes: | Z3L1 was confirmed to bind ZIKV sE protein by ELISA, with an affinity of 5.39 uM shown by SPR (Wang et al, 2016). Using a FACS-based assay, it was shown that Z3L1 was sufficient for complete neutralisation of viral activity against infected C6/36 and Vero cells. In vivo, it has been shown that Z3L1 protected IFN receptor KO mice from ZIKV infection. |
| Brand | Vector Labs |
|---|---|
| UNSPSC | 12161500 |